Our recognition
Latest stories
Featured
Hikma delivers strong 2023 performance and a positive outlook for 2024
Press Release, Financial Results
- Inspired at Hikma: Career growth, leadership and social impact. Meet Zeena Murad Story, Life at Hikma 14 May 2026 Inspired at Hikma: Career growth, leadership and social impact. Meet Zeena Murad
- Working at Hikma’s Zagreb R&D hub: meet Nera Marjanovic Story, Life at Hikma 08 May 2026 Working at Hikma’s Zagreb R&D hub: meet Nera Marjanovic
- Why the world needs more companies like Hikma. By Said Darwazah, Chief Executive Officer Insight, Corporate 07 May 2026 Why the world needs more companies like Hikma. By Said Darwazah, Chief Executive Officer
- Hikma Pharmaceuticals and Marius Pharmaceuticals announce licensing agreement for KYZATREX® (testosterone undecanoate) CIII capsules in Canada Press Release, Product 05 May 2026 Hikma Pharmaceuticals and Marius Pharmaceuticals announce licensing agreement for KYZATREX® (testosterone undecanoate) CIII capsules in Canada
Related content